| abstract |
This invention provides compounds defined by Formula (I) or a pharmaceutically acceptable salt thereof, wherein R?l, Q, Yl, Y2, Y3Y, R2a, R2b, R5¿, and n are as defined in the specification. The invention also provides pharmaceutical compositions comprising a compound of Formula (I) and the use of the compounds of Formula (I) as matrix metalloproteinase inhibitors. |